Alfresa Holdings Corporation
JPX: 2784.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Ryuji Arakawa
- Employees
- 12,517
- Headquarters
- Tokyo, Japan
- IPO year
- 2005
- Market cap
- ¥425.9B
- Website
- https://www.alfresa.com
Loading 2784…
Loading profile data…Frequently asked questions about 2784
What does Alfresa Holdings Corporation (2784.T) do?
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equ...
Where does 2784.T trade?
Alfresa Holdings Corporation (2784.T) trades on the Tokyo Stock Exchange.
What sector is 2784.T in?
Alfresa Holdings Corporation (2784.T) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Alfresa Holdings Corporation?
Ryuji Arakawa is the chief executive officer of Alfresa Holdings Corporation (2784.T).
Where is Alfresa Holdings Corporation headquartered?
Alfresa Holdings Corporation is headquartered in Japan.
Does 2784.T pay a dividend?
Yes — Alfresa Holdings Corporation (2784.T) paid a trailing twelve-month dividend of JPY 68.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2784.T go public?
Alfresa Holdings Corporation (2784.T) completed its initial public offering in 2005.